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Generation and characterization of human induced pluripotent stem cell lines from a familial Alzheimer's disease PSEN1 A246E patient and a nondemented family member bearing wild-type PSEN1 
A B S T R A C T
The induced pluripotent stem cell (iPSC) lines UOWi002-A and UOWi003-A were reprogrammed from dermal fibroblasts via mRNA transfection. Dermal fibroblasts from a 56 year old female caucasian familial Alzheimer's disease patient carrying A246E mutation in the PSEN1 gene (familial AD3, autopsy confirmed Alzheimer's disease) and a 75 year old female non-demented control from the same family bearing the wild-type PSEN1 A246 genotype were obtained from the Coriell Institute (AG06848 and AG06846, respectively). The generated iPSCs were characterized and pluripotency was confirmed. The PSEN1 genotype was maintained in both iPSC lines.
Resource Resource utility
These iPSC lines can be used as a familial Alzheimer's disease cell line model and an escapee non-demented control from the same family.
Resource details
Dermal fibroblasts from a 56 year old female Alzheimer's disease patient and a 75 year old female escapee from the same family (Nee et al., 1983) were obtained from the Coriell Institute (AG06848 and AG06846, respectively, Table 1 ). The StemMACS mRNA Reprogramming kit (Miltenyi Biotec) was used to generate the iPSC lines (UOWi003-A and UOWi002-A), following the manufacturer's instructions. The iPSC colonies were isolated and expanded as individual clones. The A246E mutation in the PSEN1 gene was confirmed present in the UOWi003-A cell line and absent in the UOWi002-A cell line ( Fig. 1A) , consistent with the parental fibroblast lines. The selected clone for each cell line showed a normal karyotype with no abnormality detected in 15 cells at 400 bands per haploid set for either of the iPSC lines (Fig. 1B) , and showed normal iPSC morphology (Fig. 1C) . The iPSC lines were authenticated against their respective fibroblast lines via short tandem repeat (STR) profiling. Characterization of the clones was carried out by immunostaining, showing expression of the pluripotent markers Oct4 and SSEA-4 (Fig. 1C) and quantitative RT-PCR (qRT-PCR) showed increased mRNA expression of the pluripotent genes POU5F1 by > 4000 fold and NANOG by 100 fold (Fig. 1D ) in the iPSCs in comparison to their parental fibroblasts. Pluripotency was confirmed via PluriTest (Müller et al., 2011) , with the UOWi002-A and UOWi003-A lines obtaining a Pluripotency Score of 24.16 and 18.64, respectively and a Novelty Score of 1.46 and 1.47, respectively (Fig. 1E) . Differentiation potential of UOWi002-A and UOWi003-A was confirmed by differentiation into endodermal, mesodermal or ectodermal lineages. cDNA from each lineage was pooled in a 1:1:1 ratio and analysed using TaqMan hPSC Scorecard. Results showed upregulation of specific genes of the endoderm, mesoderm and ectoderm layer, while pluripotent genes were downregulated (Fig. 1F) . (See Table 2 .)
Materials and methods

Reprogramming of dermal fibroblasts into iPSCs
Fibroblasts were plated on Matrigel-coated plates (Corning) and cultured in Stemgent Pluriton Reprogramming Medium before reprogramming was carried out with the StemMACS mRNA Reprogramming kit (Miltenyi Biotec, . After daily mRNA transfection for 11 days, the iPSC colonies that appeared in the cultures were manually transferred to another Matrigel-coated plate for isolation and expansion, and maintained in TeSR-E8 (Stemcell Technologies) at 37°C and 5% CO 2 . This study was approved by the University of Wollongong Human Research Ethics Committee (HE13/299).
Sequencing
DNA was extracted using the ISOLATE II Genomic DNA Kit (Bioline) and amplified by PCR using MyTaq HS DNA Polymerase (Bioline) with PSEN1 primers (Table 3) . Sequencing reactions were performed using ABI BigDye Terminator v3.1 Ready Reaction Mix, separated using 3500xL Genetic Analyzer (Applied Biosystems) and analysed using BioEdit (Fig. 1A) .
Karyotyping
Karyotyping of the iPSCs was performed by Sullivan Nicolaides Pathology Pty Ltd. (Bowen Hills, Australia) (Fig. 1B) .
Immunofluorescence staining iPSC colonies were fixed with 4% paraformaldehyde for 10 min and permeabilized with 0.05% Triton-X for 15 min. Blocking was performed by incubation with 5% goat serum for 1 h at 22°C and primary antibodies (Table 3) were incubated overnight at 4°C. Samples were incubated with secondary antibody (Table 3) for 1 h at 22°C followed by RedDot2 (1:200, Biotium) or Hoescht 33,342 (1 μg/ml, Life Technologies) for 10 min. Images were captured on a confocal microscope (Leica DMI6000B) and acquired using LAS AF software (Leica Microsystems) (Fig. 1C) .
Quantitative reverse transcription polymerase chain reaction mRNA was extracted using TriReagent (MRC Gene), DNA was removed using Turbo DNAse kit (ThermoFisher Scientific) and cDNA was generated using Tetro Reverse Transcriptase (Bioline) as per manufacturer's instructions. POU5F1 and NANOG expression was assessed in triplicate using SensiFast SYBR (Bioline) on Corbett RotorGene3000 (ThermoFisher Scientific), using GAPDH and HPRT1 housekeeper genes (Fig. 1D, Table 3 ). The efficiency of each sample was determined using LinRegPCR (Ruijter et al., 2009 ) and analysis was performed using the ΔΔCt method.
PluriTest mRNA was analysed using Illumina HT 12v4 gene expression microarray via PluriTest (Müller et al., 2011) (Fig. 1E) .
TaqMan hPSC scorecard
Direct differentiation of iPSC colonies to the three germ layers was performed. Endoderm was induced with STEMdiff Definitive Endoderm Kit (Stemcell Technologies). Mesoderm was induced using Mesoderm base medium (DMEM/F12, 0.5% FBS, 1% GlutaMAX, 1% MEM Nonessential aminoacids, 55 μM 2-mercaptoethanol, 45 μM ascorbic acid) with 100 ng/ml Activin A (only on day 1), 10 ng/ml FGF-2, 100 ng/ml BMP4 and 100 ng/ml VEGF for 7 days. Ectoderm was induced using Neural induction medium (DMEM/F12, 0.4% B27, 1% N2, 1% GlutaMAX, 1% MEM Non-essential aminoacids) with 1 μM LDN193189 for 2 days as iPSC colonies, and 2 μM SB431542 and 3 μM CHIR99021 for 7 days as embryoid bodies. cDNA from each culture was mixed in a 1:1:1 ratio to analyse 1 μg by TaqMan hPSC Scorecard (ThermoFisher) as per the manufacturer's instructions.
STR analysis
STR analysis of 18 locations was performed at Garvan Molecular Genetics Institute (Darlinghurst, Australia). Stem Cell Research 31 (2018) 227-230 
